Delivery Order SPE2DR25D1053-SPE2DR26FV657
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,037.29 to AmerisourceBergen Drug Corp on January 12, 2026, for the supply of OxyContin ER 10 mg tablets in quantities of 100. This is a firm fixed-price, non-set-aside contract with a completion date of January 13, 2026, and performance at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., is a major pharmaceutical distributor serving federal healthcare systems,...
- The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $6,319.02 to AmerisourceBergen Drug Corporation's Corporate Office division. The contract is for the supply of 4,565,735 units of OxyContin ER 40 mg tablets, with a period of performance through September 10, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and DLA Troop Support Medical, valued at up to $999,999,999 and running through...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a $2,370.38 delivery order contract on September 18, 2025, for the supply of OxyContin ER 20 mg tablets (100-count units). The contract is structured as a firm fixed-price delivery order with a completion date of September 19, 2025, and represents a non-set-aside competitive award. The awardee will perform the work at its corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for OxyContin ER 15 mg tablets (100s) on January 8, 2026, with a ceiling value of $1,421.74 and an ultimate completion date of January 9, 2026. This is a firm fixed-price, non-set-aside delivery order that will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a continuation of the company's pharmaceutical supply services to the federal government under its parent...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 6, 2025, for the supply of OxyContin ER 20 mg tablets in quantities of 100 units, with a ceiling value of $3,215.89. This is a firm fixed price, competitively awarded delivery order with no set-aside designation. The contract is scheduled for ultimate completion on November 7, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a critical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 8, 2025, for the supply of OxyContin ER 30 mg tablets in quantities of 100 units, with a ceiling value of $1,045.05. This is a firm fixed-price delivery order with an ultimate completion date of December 9, 2025, and represents a non-competitive set-aside contract. The order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, the company's headquarters....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 9, 2026, for the supply of OxyContin ER 40 mg tablets in quantities of 100 units. This $6,962.52 firm fixed-price delivery order, with an ultimate completion date of January 12, 2026, supports federal pharmaceutical procurement needs through a competitive, non-set-aside award. The work will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 9, 2025, for the supply of OxyContin ER 80 mg tablets in quantities of 100, with a contract ceiling value of $9,918.28. This is a firm fixed-price delivery order issued under a competitive procurement with no set-aside designation. The order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of December 10, 2025. This...
- The U.S. Defense Logistics Agency, through its Medical Supply Chain, awarded a delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of OxyContin ER 80 mg tablets (100-count units) valued at $1,796.20. This is a firm fixed-price delivery order with an ultimate completion date of September 24, 2025, representing a single-transaction purchase of pharmaceutical inventory. The contract was competitively awarded without set-aside designation, leveraging...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 5, 2025, for the supply of OxyContin ER 20 mg tablets (100-count units) with a ceiling value of $1,468.84. This competitively awarded, firm fixed-price delivery order is scheduled for completion by December 8, 2025, with performance based in Conshohocken, Pennsylvania. The contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support...
- SPE2DR25D1053Indefinite Delivery Contract
- SPE2DR25D1053-SPE2DR26FV657Delivery Order
The Defense Logistics Agency awarded a delivery order to Amerisourcebergen Drug Corp (a subsidiary of Cencora, Inc.) on January 20, 2026, for the supply of OxyContin ER 20 mg tablets in quantities of 100 units. This is a firm fixed-price delivery order with a ceiling value of $3,384.40 and an ultimate completion date of January 21, 2026. The contract was awarded on a competitive basis with no set-aside designation. The place of performance is Conshohocken, Pennsylvania, where Amerisourcebergen maintains its corporate headquarters and primary operations. This delivery order operates under Amerisourcebergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (contract number SPE2DX), valued at up to $999,999,999.00 and extending through December 2026. This comprehensive IDC serves as a global pharmaceutical support vehicle enabling the supply of a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, vaccines, and other critical medical commodities. The DLA Troop Support Medical utilizes this contract vehicle to supply the Defense Health Agency, U.S. Coast Guard, and other federal government healthcare systems with essential pharmaceutical products required for military treatment facilities and veteran healthcare programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.4k | 1/19/26 |